These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 2970262)

  • 1. Evidence for 5-HT1A binding sites in chick embryo brain and discrimination by 5-methoxytryptamine.
    Soblosky JS; Dills C; DuMontier G; Jeng I
    Biochem Int; 1987 May; 14(5):797-803. PubMed ID: 2970262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 125I-Bolton-Hunter-8-methoxy-2-[N-propyl-N-propylamino]tetralin as a new selective radioligand of 5-HT1A sites in the rat brain. In vitro binding and autoradiographic studies.
    Gozlan H; Ponchant M; Daval G; Verge D; Menard F; Vanhove A; Beaucourt JP; Hamon M
    J Pharmacol Exp Ther; 1988 Feb; 244(2):751-9. PubMed ID: 2964524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Canine basilar artery contractions mediated by 5-hydroxytryptamine1A receptors.
    Peroutka SJ; Huang S; Allen GS
    J Pharmacol Exp Ther; 1986 Jun; 237(3):901-6. PubMed ID: 2940360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin-1A receptor activation in hippocampal CA1 neurons by 8-hydroxy-2-(di-n-propylamino)tetralin, 5-methoxytryptamine and 5-hydroxytryptamine.
    Wu PH; Gurevich N; Carlen PL
    Neurosci Lett; 1988 Mar; 86(1):72-6. PubMed ID: 2966313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential selectivities of RU 24969 and 8-OH-DPAT for the purported 5-HT1A and 5-HT1B binding sites. Correlation between 5-HT1A affinity and hypotensive activity.
    Doods HN; Kalkman HO; De Jonge A; Thoolen MJ; Wilffert B; Timmermans PB; Van Zwieten PA
    Eur J Pharmacol; 1985 Jun; 112(3):363-70. PubMed ID: 3160596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological differentiation and characterization of 5-HT1A, 5-HT1B, and 5-HT1C binding sites in rat frontal cortex.
    Peroutka SJ
    J Neurochem; 1986 Aug; 47(2):529-40. PubMed ID: 2942638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of the 5-HT1A receptor and 5-HT1A receptor mRNA in the rat bowel and pancreas: comparison with 5-HT1P receptors.
    Kirchgessner AL; Liu MT; Howard MJ; Gershon MD
    J Comp Neurol; 1993 Jan; 327(2):233-50. PubMed ID: 8425944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotonin-induced reduction of the calcium-dependent plateau in frog dorsal root ganglion cells is blocked by serotonergic agents acting at 5-hydroxytryptamine1A sites.
    Marszalec W; Scroggs RS; Anderson EG
    J Pharmacol Exp Ther; 1988 Nov; 247(2):399-404. PubMed ID: 2972829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Further evidence that indorenate is a 5-HT1 agonist.
    Benítez-King G; Chávez JL; Martínez I; Antón-Tay F; Hong E
    Proc West Pharmacol Soc; 1991; 34():433-7. PubMed ID: 1838609
    [No Abstract]   [Full Text] [Related]  

  • 10. Single-unit responses of serotonergic dorsal raphe neurons to 5-HT1A agonist and antagonist drug administration in behaving cats.
    Fornal CA; Litto WJ; Metzler CW; Marrosu F; Tada K; Jacobs BL
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1345-58. PubMed ID: 7932189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A drug discrimination analysis of the actions of novel serotonin1A receptor ligands in the rat using the 5-HT1A receptor agonist, 8-hydroxy-2-(di-n-propylamino)tetralin.
    Schreiber R; Brocco M; Lefèbvre de Ladonchamps B; Monneyron S; Millan MJ
    J Pharmacol Exp Ther; 1995 Nov; 275(2):822-31. PubMed ID: 7473172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a 5-HT1 recognition site in human brain membranes different from 5-HT1A, 5-HT1B and 5-HT1C sites.
    Hoyer D; Waeber C; Pazos A; Probst A; Palacios JM
    Neurosci Lett; 1988 Mar; 85(3):357-62. PubMed ID: 2966310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [125I-BH-8-MeO-N-PAT, a new ligand for the study of 5-HT1A receptors in the central nervous system].
    Ponchant M; Beaucourt JP; Vanhove A; Daval G; Vergé D; Hamon M; Gozlan H
    C R Acad Sci III; 1988; 306(4):147-52. PubMed ID: 2965963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the aminomethylchroman derivative BAY x 3702 as a highly potent 5-hydroxytryptamine1A receptor agonist.
    De Vry J; Schohe-Loop R; Heine HG; Greuel JM; Mauler F; Schmidt B; Sommermeyer H; Glaser T
    J Pharmacol Exp Ther; 1998 Mar; 284(3):1082-94. PubMed ID: 9495870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-HT transporter sites and 5-HT1A and 5-HT3 receptors in Fawn-Hooded rats: a quantitative autoradiography study.
    Chen F; Lawrence AJ
    Alcohol Clin Exp Res; 2000 Jul; 24(7):1093-102. PubMed ID: 10924015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indorenate modifies a1-adrenergic and benzodiazepine receptor binding in the rat brain: an autoradiography study.
    López-Meraz ML; Neri-Bazán L; Rocha L
    J Pharm Pharmacol; 2006 Sep; 58(9):1243-8. PubMed ID: 16945183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New sigma and 5-HT1A receptor ligands: omega-(tetralin-1-yl)-n-alkylamine derivatives.
    Berardi F; Colabufo NA; Giudice G; Perrone R; Tortorella V; Govoni S; Lucchi L
    J Med Chem; 1996 Jan; 39(1):176-82. PubMed ID: 8568804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-Hydroxytryptamine stimulates two distinct adenylate cyclase activities in rat brain: high-affinity activation is related to a 5-HT1 subtype different from 5-HT1A, 5-HT1B, and 5-HT1C.
    Fayolle C; Fillion MP; Barone P; Oudar P; Rousselle JC; Fillion G
    Fundam Clin Pharmacol; 1988; 2(3):195-214. PubMed ID: 3402898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological characterization of LY293284: A 5-HT1A receptor agonist with high potency and selectivity.
    Foreman MM; Fuller RW; Rasmussen K; Nelson DL; Calligaro DO; Zhang L; Barrett JE; Booher RN; Paget CJ; Flaugh ME
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1270-81. PubMed ID: 7523657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The selective labelling of central 5-HT1A receptor binding sites by [3H]5-methoxy-3-(di-n-propylamino)chroman.
    Cossery JM; Gozlan H; Spampinato U; Perdicakis C; Guillaumet G; Pichat L; Hamon M
    Eur J Pharmacol; 1987 Aug; 140(2):143-55. PubMed ID: 2959487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.